Here, we report that BACH transcription factors, which are known to be involved in various intracellular signaling pathways, modulate VEGFC expression during embryonic development and tumor progression, offering a better understanding of blood and lymph vessel formation during physiological and pathological conditions. The gene discussed is VEGFC; the disease is neoplasm.